Met Life Investment Management, LLC Biote Corp. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Biote Corp. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 16,582 shares of BTMD stock, worth $100,155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,582
Previous 7,239
129.06%
Holding current value
$100,155
Previous $54,000
70.37%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BTMD
# of Institutions
83Shares Held
17.7MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$27.5 Million13.05% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$14.7 Million5.13% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$9.69 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$8.56 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.39MShares$8.41 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $45.7M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...